Efficacy/Safety of Meropenem-Vaborbactam Compared to Piperacillin-Tazobactam in Adults With cUTI and AP

NCT02166476 · clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
550
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Melinta Therapeutics, Inc.

Collaborators